Pfizer’s shot left fewer than half of participants with side effects
A second experimental coronavirus vaccine being tested by Pfizer Inc and its German partner BioNTech SE showed promising results. The two companies say their second jab produced just as many antibodies in volunteers as their first jab did, but had far fewer side effects. Results published on Wednesday in The New England Journal of Medicine … Read more